Ata is a high‐frequency red blood cell (RBC) antigen. Anti‐Ata has been reported in rare At(a–) black subjects. We report two cases of anti‐Ata. A clinically significant anti‐Ata was found in a 26‐year‐old black woman with systemic lupus erythematosus. The patient had a transfusion reaction with chills and nausea during a RBC survival study, and 95% of the radiolabeled At(a+) RBCs were destroyed within 3 h. A concurrently performed monocyte monolayer assay was strongly reactive. Anti‐Ata thus can cause rapid hemolysis of transfused RBCs, but At(a–) donor units are extremely scarce in rare donor registries. A second patient at our hospital had anti‐Ata which did not affect her newborn. She also had autoimmune disease, insulin‐dependent diabetes mellitus.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Aug 1995|
ASJC Scopus subject areas